Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma

• Yung-Luen Yu ,

  Contributed equally to this work with: Yung-Luen Yu, Kuo-Jung Su

  Affiliations Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan, The Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University, Taichung, Taiwan, Department of Biotechnology, Asia University, Taichung, Taiwan

  ⨯
• Kuo-Jung Su ,

  Contributed equally to this work with: Yung-Luen Yu, Kuo-Jung Su

  Affiliation The Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University, Taichung, Taiwan

  ⨯
• Yi-Hsien Hsieh,

  Affiliation Institute of Biochemistry and Biotechnology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan

  ⨯
• Hsiang-Lin Lee,

  Affiliations Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan

  ⨯
• Tzy-Yen Chen,

  Affiliations School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

  ⨯
• Pei-Ching Hsiao,

  Affiliations School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

  ⨯
• Shun-Fa Yang

  * E-mail: ysf@csmu.edu.tw

  Affiliations Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan

  ⨯